Skip to main content
OpenTrials
Completed

NCT Number: NCT01402830

Case-control Study- Cancer Pain: Uncontrolled Pain as Depression Development Predictor in Oncologic Patients (Fentanyl)

The purpose of this study is to evaluate the relationship between cancer pain and risk of depression among cancer patients.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

About this study

This is a retrospective observational and case-control multicenter study. The main objective of this study is determine the degree of association between cancer pain and depression by impact assessment of adequate control of pain associated with cancer risk depression in patients attending the Oncology Unit. The assessment of pain intensity will be performed by using visual analogue scales (EVAs) and verbal descriptive scales, as an observational study, not limit or modify the use of any drug. The patients included in this study have a medical history of cancer pain and mild depression (Beck = 8). The controls are patients with history of cancer pain and mild or absent depression (Beck = 7). n/a

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients =18 years old
  • have medical data of = 3 months
  • experience pain after cancer diagnosis and complete the Beck Depression Inventory (BDI)
  • patients who give informed written consent
  • patients with no mental or physical disorders that unable them to complete the BDI.

Exclusion criteria

  • Patients with diagnosis of depression before cancer diagnosis
  • patients with chronic pain prior to the diagnosis of cancer, and cancer disease has not changed its course
  • patients with other previous mental disorders
  • patients who do not give their informed written consent.

Treatment and study plan

Visual analogue scales (EVAs)

Other

This scale measures the pain intensity.

Primary outcomes

  1. Beck Depression Inventory

    Time frame: 3 months

  2. Visual scales analog (EVAs)

    Time frame: 3 months

Secondary outcomes

  1. Number of patients with cancer pain.

    Time frame: 3 months

Sponsors and collaborators

Lead sponsor

Janssen-Cilag, S.A.

Industry

Registry information

Official study title

DPRESS Study. Case-control Study in Cancer Pain: Uncontrolled Pain as Depression Development Predictor in Oncologic Patients

Important dates

Study start
2007
Primary completion
2008
Study completion
2008
First posted
Jul 26, 2011
Registry last updated
Feb 11, 2013

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.